Details for New Drug Application (NDA): 200908
✉ Email this page to a colleague
The generic ingredient in LABETALOL HYDROCHLORIDE is labetalol hydrochloride. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the labetalol hydrochloride profile page.
Summary for 200908
Tradename: | LABETALOL HYDROCHLORIDE |
Applicant: | Endo Operations |
Ingredient: | labetalol hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 200908
Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 200908
Suppliers and Packaging for NDA: 200908
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 200908 | ANDA | Endo USA, Inc. | 49884-122 | 49884-122-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (49884-122-01) |
LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 200908 | ANDA | Endo USA, Inc. | 49884-122 | 49884-122-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (49884-122-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Jul 10, 2012 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Jul 10, 2012 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | Jul 10, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription